Medication Review Inc Spokane, WA - 99202

Medication Review Inc is categorized under Hospital Management in Spokane, WA and active since 2005.

Medication Review Inc was established in 2005, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hospital Management business, which does work in the B2B market, and is classified as a Hospital Management, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Jennifer Baudino, Manager at the company’s single location by writing to 104 South Freya St # 119, Spokane, Washington WA 99202 or by phoning (509) 536-1900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medication Review Inc
Contact Person: Jennifer Baudino, Manager
Address: 104 South Freya St # 119, Spokane, Washington 99202
Phone Number: (509) 536-1900
Website Address: medicationreview.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Hospital Management
SIC Code: 8741
NAICS Code: 4461100
Share This Business:

Medication Review Inc was started in 2005 to provide professional Hospital Management under the SIC code 8741 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Jennifer Baudino, Manager for inquiries that concern Medication Review Inc by calling the company number (509) 536-1900, as your correspondence is most welcome. Additionally, the physical location of the single location of Medication Review Inc can be found at the coordinates 47.65598,-117.35777 as well as the street address 104 South Freya St # 119 in Spokane, Washington 99202.

For its online presence, you may visit Medication Review Inc’s website at medicationreview.com and engage with its social media outlets through on Twitter and on Facebook.